Vesalius Biocapital is a European life sciences venture capital investor. The active fund Vesalius Biocapital III had a first closing in May 2017 – currently, over € 75 million are managed.
Investment Type: Venture Capital
Portfolio 10
| Date | Name | Website | Total Raised | Location |
| - | Memo Thera... | memo-therapeutics.com | $106.22M | Switzerlan... |
| - | Tonic App | tonicapp.com | $3.89M | Portugal, ... |
| - | Caresyntax | caresyntax.com | $453.8M | United Sta... |
| - | Scenic Bio... | scenicbiotech.com | $38.39M | Netherland... |
| - | Rejuvenate... | rejuvenatebiomed.com | $18.14M | Belgium, L... |
| - | Topas Ther... | topas-therapeutics.com | $63.15M | Germany, H... |
| - | Mecuris | mecuris.com | $8.12M | Germany, B... |
| - | Forendo Ph... | forendo.com | $13.93M | - |
| - | DEARhealth | dearhealth.com | $6.8M | United Sta... |
| - | Catalym | catalym.com | $261.12M | Germany, B... |
Mentions in press and media 2
| Date | Title | Description |
| 17.02.2020 | Internacional: OncoDNA cierra una ronda Serie B de €19M, acuden Vesalius Biocapital, Swisscanto Invest, SFPI y otros | 17/02/2020 Nota de prensa INTERNACIONAL: ONCODNA CIERRA UNA RONDA SERIE B DE €19 MILLONES, ACUDEN VESALIUS BIOCAPITAL, SWISSCANTO INVEST, SFPI Y OTROS. Se suman a su accionariado el fondo de capital riesgo europeo Vesalius Biocapital III... |
| 25.06.2019 | Vesalius Biocapital III Closes €120M Life Sciences Focused Fund | Vesalius Biocapital III, the Strassen, Luxembourg-based specialist life sciences venture capital investor, closed the VBC III fund, securing €120m of equity commitments. This includes commitments of €30 million from the European Investment ... |